Bjorn Glinghammar
Karolinska Institutet
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bjorn Glinghammar.
Nutrition and Cancer | 2000
Ana I. Haza; Bjorn Glinghammar; Alf Grandien; Joseph Rafter
Apoptosis is central to cell number regulation in the colonic epithelium, and interest in its role in colon carcinogenesis has been growing rapidly. It thus becomes of interest to characterize luminal components, possibly of dietary origin, that may influence this process. We have investigated the sensitivity of two human colonic cell lines, the human adenocarcinoma cell line (HT-29) and the human fetal colonic mucosa cell line (FHC), to induction of apoptosis by sodium butyrate, bile acids, and human fecal water fractions. The apoptotic effect has been studied by 1) morphological changes in cells examined by fluorescence microscopy, 2) DNA fragmentation analysis by gel electrophoresis, 3) flow cytometry analysis of DNA strand breaks assessed by the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay (TUNEL), and 4) poly(ADP-ribose) polymerase cleavage by Western blot. Sodium butyrate and bile acids induced a time- and concentration-dependent apoptosis in both cell lines. Quantitation of this effect, by use of the TUNEL assay, indicated that deoxycholic acid was most effective in inducing this effect at lower concentrations and at shorter times. Apoptotic effects were also observed, in both cell lines, when the cells were exposed to intact human fecal waters (the fecal fraction in direct contact with the epithelium) and their lipid extracts, with the intact samples being more effective. Although all fecal waters examined induced apoptosis, quantitation of the effect by the TUNEL assay indicated that the ability to induce apoptosis differed markedly between samples. Induction of apoptosis by the fecal waters was not correlated to cytotoxicity but was negatively correlated to the pH of the samples. Interestingly, the cells derived from the fetal mucosa (FHC) were consistently less sensitive to apoptotic effects of the luminal components than the tumor-derived cells (HT-29). Thus human fecal water fractions induce apoptosis in colonic cells, and this effect is not due to lipid components alone.
European Journal of Cancer Prevention | 1998
Joseph Rafter; Bjorn Glinghammar
Colorectal cancer is now widely accepted to be the result of an accumulation of mutations in specific genes controlling cell division, apoptosis and DNA repair. There is also a wealth of evidence that dietary factors, including dietary fat and fibre, influence the development of colorectal cancer. However, until recently, there has been little understanding of how these dietary factors and genetic factors interact. It is generally believed that this interaction is mediated in part by events occurring in the lumen of the large bowel. By characterizing the dietary/luminal factors that interact with the genes implicated in tumour development in the colon, a new understanding of colorectal cancer is likely to emerge, hopefully leading to the formulation of dietary recommendations to decrease the risk of this cancer.
Biomarkers | 2017
Petra Thulin; Robert James Hornby; Mariona Aulí; Gunnar Nordahl; Daniel J. Antoine; Philip J. Starkey Lewis; Christopher E. Goldring; B. Kevin Park; Neus Prats; Bjorn Glinghammar
Abstract Context: There is an ongoing search for specific and translational biomarkers of drug-induced liver injury (DILI). MicroRNA-122 (miR-122) has previously shown potential as a sensitive, specific, and translational biomarker of DILI in both rodent, and human studies. Objective: To build on previous work within the field, we examined biomarker kinetics in a rat model of acetaminophen (APAP)-induced liver injury to confirm the sensitivity, and specificity of miR-122 and glutamate dehydrogenase (GLDH). Materials and methods: qRT-PCR and a standard enzymatic assay were used for biomarker analysis. Results: Both miR-122 and GLDH were demonstrated to be more readily-detectable biomarkers of APAP-DILI than alanine aminotransferase (ALT). Peak levels for all biomarkers were detected at 2 days after APAP. At day 3, miR-122 had returned to baseline; however, other biomarkers remained elevated between 3 and 4 days. We were also able to demonstrate that, although miR-122 is present in greater quantities in exosome-free form, both exosome-bound and non-vesicle bound miR-122 are released in a similar profile throughout the course of DILI. Discussion and conclusions: Together, this study demonstrates that both GLDH and miR-122 could be used during preclinical drug-development as complementary biomarkers to ALT to increase the chance of early detection of hepatotoxicity.
Carcinogenesis | 1997
Miro Venturi; Richard J.Hambly; Bjorn Glinghammar; Joseph Rafter; Ian Rowland
Carcinogenesis | 2002
Bjorn Glinghammar; Hiroyasu Inoue; J.J. Rafter
The American Journal of Clinical Nutrition | 1997
Bjorn Glinghammar; M Venturi; I R Rowland; Joseph Rafter
Biochemical and Biophysical Research Communications | 2003
Bjorn Glinghammar; Josefin Skogsberg; Anders Hamsten; Ewa Ehrenborg
Gastroenterology | 2001
Bjorn Glinghammar; Joseph Rafter
Carcinogenesis | 1999
Bjorn Glinghammar; Kristina Holmberg; Joseph Rafter
International Journal of Molecular Medicine | 2006
Katja Kannisto; Alexander V. Chibalin; Bjorn Glinghammar; Juleen R. Zierath; Anders Hamsten; Ewa Ehrenborg